tiprankstipranks
R1 RCM price target raised to $18 from $14 at RBC Capital
The Fly

R1 RCM price target raised to $18 from $14 at RBC Capital

RBC Capital analyst Sean Dodge raised the firm’s price target on R1 RCM to $18 from $14 and keeps an Outperform rating on the shares ahead of its Q4 results. Publicized hiccups during the Pediatrix/LifePoint implementations have weighed heavily on shares, and are likely keeping new investors sidelined until there’s more evidence these issues are resolved, the analyst tells investors in a research note. The firm adds however that R1 RCM continues to be its favorite idea on "high" conviction in a 3-year mid/high-teens EBITDA CAGR outlook.

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on RCM:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles